| Okey Iloegbunam, FNP | |
|
1510 E Wagon Wheel Ln Ste 110, Fort Mohave, AZ 86426-6698 | |
| (928) 788-3333 | |
| (928) 788-3555 |
| Full Name | Okey Iloegbunam |
|---|---|
| Gender | Male |
| Speciality | Nurse Practitioner |
| Experience | 7 Years |
| Location | 1510 E Wagon Wheel Ln Ste 110, Fort Mohave, Arizona |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1477072130 | NPI | - | NPPES |
| 339857 | Medicaid | AZ |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Tri-state Medical Specialists Llc | 1850422023 | 3 |
| Tri-state Medical Specialists Llc | 1850422023 | 3 |
News Archive
The implant, manufactured by Santa Barbara-based Sientra, can be used for breast tissue reconstruction for women of any age and for breast augmentation in women 22 or older. The approval resulted from three years of clinical studies on almost 1,800 patients. Tightening of the area around the implant, re-operation, implant removal, uneven appearance and infection were some of the complications experienced during the study. Sientra is required to continue studies on the implant's long-term safety, effectiveness and risks of rare diseases under the approval.
Researchers at Columbia University recently analyzed the positive effects of Modified Citrus Pectin (MCP) on human and mouse prostate cancer cell lines. The results, as reported by lead researcher Dr. Aaron Katz in the most recent publication of Integrative Cancer Therapies, show that MCP inhibits cell proliferation and induces apoptosis (programmed cell death) in both androgen-dependent and androgen-independent cancer cells in a time and dose-dependent manner.
Physicians understand frailty as a dysregulation among multiple systems in the body that make it less resilient and unable to recover completely when faced with a physical challenge such as injury or illness.
Today's early morning highlights from the major news organizations, including an array of stories as the health law's enrollment period comes to a close
› Verified 4 days ago
| Entity Name | Tri-state Medical Specialists Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1649598426 PECOS PAC ID: 1850422023 Enrollment ID: O20100702000024 |
News Archive
The implant, manufactured by Santa Barbara-based Sientra, can be used for breast tissue reconstruction for women of any age and for breast augmentation in women 22 or older. The approval resulted from three years of clinical studies on almost 1,800 patients. Tightening of the area around the implant, re-operation, implant removal, uneven appearance and infection were some of the complications experienced during the study. Sientra is required to continue studies on the implant's long-term safety, effectiveness and risks of rare diseases under the approval.
Researchers at Columbia University recently analyzed the positive effects of Modified Citrus Pectin (MCP) on human and mouse prostate cancer cell lines. The results, as reported by lead researcher Dr. Aaron Katz in the most recent publication of Integrative Cancer Therapies, show that MCP inhibits cell proliferation and induces apoptosis (programmed cell death) in both androgen-dependent and androgen-independent cancer cells in a time and dose-dependent manner.
Physicians understand frailty as a dysregulation among multiple systems in the body that make it less resilient and unable to recover completely when faced with a physical challenge such as injury or illness.
Today's early morning highlights from the major news organizations, including an array of stories as the health law's enrollment period comes to a close
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Okey Iloegbunam, FNP Po Box 10966, Fort Mohave, AZ 86427-0966 Ph: (928) 788-3333 | Okey Iloegbunam, FNP 1510 E Wagon Wheel Ln Ste 110, Fort Mohave, AZ 86426-6698 Ph: (928) 788-3333 |
News Archive
The implant, manufactured by Santa Barbara-based Sientra, can be used for breast tissue reconstruction for women of any age and for breast augmentation in women 22 or older. The approval resulted from three years of clinical studies on almost 1,800 patients. Tightening of the area around the implant, re-operation, implant removal, uneven appearance and infection were some of the complications experienced during the study. Sientra is required to continue studies on the implant's long-term safety, effectiveness and risks of rare diseases under the approval.
Researchers at Columbia University recently analyzed the positive effects of Modified Citrus Pectin (MCP) on human and mouse prostate cancer cell lines. The results, as reported by lead researcher Dr. Aaron Katz in the most recent publication of Integrative Cancer Therapies, show that MCP inhibits cell proliferation and induces apoptosis (programmed cell death) in both androgen-dependent and androgen-independent cancer cells in a time and dose-dependent manner.
Physicians understand frailty as a dysregulation among multiple systems in the body that make it less resilient and unable to recover completely when faced with a physical challenge such as injury or illness.
Today's early morning highlights from the major news organizations, including an array of stories as the health law's enrollment period comes to a close
› Verified 4 days ago